TRIBRISSEN WATER MEDICATION

Main information

  • Trade name:
  • TRIBRISSEN WATER MEDICATION
  • Pharmaceutical form:
  • ORAL SOLUTION/SUSPENSION
  • Units in package:
  • 200mL
  • Class:
  • Veterinary Medicine
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug
  • Manufactured by:
  • INTERVET AUSTRALIA

Documents

Localization

  • Available in:
  • TRIBRISSEN WATER MEDICATION
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • PIGS | POULTRY | TURKEYS | BOAR | BREEDER | BREEDERS | BROILER | BROILER BREEDER | CHICKENS | CHICKS | CHOOKS | DAY OLD CHICKS |
  • Therapeutic area:
  • antibiotic
  • Therapeutic indications:
  • BACTERIAL INFECTION | DIARRHOEA | ESCHERICHIA COLI (E. COLI) | HAEMOPHILUS SPP. | PASTEURELLA SPP. | SALMONELLA | STAPHYLOCOCCI | ABSORPTIVE | ACUTE DIARRHOEA | ACUTE INTESTINAL CATARRH | AMOXYCILLIN SENSITIVE BACTERIA | ASSOCIATED WITH VIRAL DISEASE | AVIAN BLACKHEAD | BACTERIAL ENTERITIS | BLACKHEAD | CHRONIC DIARRHOEA | COCCIDIOSIS | DIETARY FACTORS | DIETARY UPSET | ENTERITIS | FEED CONVERSION | FLATULANCE | FLUID LOSS | GASTRO-INTESTINAL | GRAM NEGATIVE BACTERIA | GRAM NEGATIVE ORGANISMS | GRAM POSITIVE ORGANISMS | GROWTH RATE | HAEMOPHILUS AGNI | HAEMOPHILUS BOVIS | HAEMOPHILUS PARAINFLUENZAE | HAEMOPHILUS PARASUIS | HAEMOPHILUS PLEUROPNEUMONIAE | HAEMOPHILUS SOMNUS | HAEMOPHILUS SUIS | INCLUDING B-LACTAMASE PRODUCIN | K88+ SEROTYPES OF E.COLI | NESTING DIARRHOEA | NON-SPECIFIC IRRITANTS | PASTERELLOSIS | PASTEURELLOSIS | POISONING | POST PARTURIENT BACTERIAL INFE | POSTWEANING SCOURS | PRIMARY BACTERIAL INFECTION | PROPHYLACTIC | SALMONELLOSIS | SCOURS | STREPTOMYCIN SENSITIVE BACTERI | SULFADIAZINE SE
  • Product summary:
  • For the treatment of bacterial infections sensitive to trimethoprim and sulfadiazine in chickens, turkeys and pigs.This product is unsuitable for use in unweaned piglets less than 15-20 days old.

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Registered but not available
  • Authorization number:
  • 36123/0500
  • Authorization date:
  • 29-06-2000
  • Last update:
  • 15-06-2017

Patient Information leaflet: composition, indications, side effects, dosage, interactions, adverse reactions, pregnancy, lactation

36123_0500c.doc

Revision: 11/5/2000

Page 1 of 4

TRIBRISSEN WATER MEDICATION – PRIMARY PACK

200mL CARTON

MAIN PANEL AND REAR PANEL

PRESCRIPTION ANIMAL REMEDY

KEEP OUT OF REACH OF CHILDREN

FOR ANIMAL TREATMENT ONLY

TRIBRISSEN®

WATER MEDICATION

TRIMETHOPRIM 80 g/L

SULFADIAZINE 400 g/L

For the treatment of bacterial infections

sensitive to trimethoprim and sulfadiazine

in chickens, turkeys and pigs.

200 mL

JUROX LOGO

TRIBRISSEN WATER MEDICATION – PRIMARY PACK

200mL CARTON

TOP PANEL

TRIBRISSEN®

WATER MEDICATION

TRIMETHOPRIM 80 g/L

SULFADIAZINE 400 g/L

200 mL

PICTURE OF

BOTTLE

Info

pest

Verified

36123_0500c.doc

Revision: 11/5/2000

Page 2 of 4

TRIBRISSEN WATER MEDICATION – PRIMARY PACK

200mL CARTON

SIDE PANEL (1)

DIRECTIONS FOR USE:

SHAKE BOTTLE WELL BEFORE USE.

DO NOT USE in birds which are producing or may in the future produce eggs or egg

products for human consumption.

Due to inadequate water consumption, this product is unsuitable for use in unweaned

piglets less than 15-20 days old.

Slowly add measured volume to water in medication tank, stirring thoroughly.

DILUTION RATES:

Treatment of

E. coli

, Pasteurella Haemophilus and Staphylococcal infections in chickens:-

1mL to 4.5 litres water.

Treatment of Salmonella infection of chickens and diarrhoea in pigs:- 3mL to 4.5 litres

water.

Treatment of bacterial infections in turkeys:- 15mL per 500 kg flock liveweight in water

consumed daily.

Recommended dilution rates apply when water consumption is normal; if sub-normal,

increase concentration to administer 15-30 mg active ingredients per kg total liveweight per

day. Continue treatment for 3-5 days according to severity of disease.

Any variation by the prescribing veterinarian to the approved dose, frequency,

duration, route, disease or target species may result in the need to extend the approved

withholding period.

TRIBRISSEN WATER MEDICATION – PRIMARY PACK

200mL CARTON

SIDE PANEL (2)

WITHHOLDING PERIODS:

DO NOT USE less than 14 days before slaughter for human consumption.

DO NOT USE in birds which are producing or may in the future produce eggs or egg

products for human consumption.

Made in Australia by:

JUROX Pty. Ltd., 85 Gardiners Road, Rutherford NSW 2320 Australia

Infoline 1 800 023 312

Under licence from:

Schering-Plough Animal Health

(A Division of Schering-Plough Pty Ltd)

® Schering-Plough Pty Ltd Registered Trademark

DISPOSE of container by wrapping with paper and putting in garbage.

STORE below 25

C (Air Conditioning).

PROTECT FROM LIGHT.

EXP.

NRA 36123/0500

36123_0500c.doc

Revision: 11/5/2000

Page 3 of 4

TRIBRISSEN WATR MEDICATION – IMMEDIATE CONTAINER

200mL LABEL

MAIN PANEL

PRESCRIPTION ANIMAL REMEDY

KEEP OUT OF REACH OF CHILDREN

FOR ANIMAL TREATMENT ONLY

TRIBRISSEN®

WATER MEDICATION

TRIMETHOPRIM 80 g/L

SULFADIAZINE 400 g/L

For the treatment of bacterial infections

sensitive to trimethoprim and sulfadiazine

in chickens, turkeys and pigs.

200 mL

JUROX LOGO

PICTURE OF

BOTTLE

36123_0500c.doc

Revision: 11/5/2000

Page 4 of 4

TRIBRISSEN WATER MEDICATION – IMMEDIATE CONTAINER

200mL LABEL

SIDE PANEL (1)

DIRECTIONS FOR USE: SHAKE BOTTLE WELL BEFORE USE.

DO NOT USE in birds which are producing or may in the future produce eggs or egg

products for human consumption.

Due to inadequate water consumption, this product is unsuitable for use in unweaned

piglets less than 15-20 days old.

Slowly add measured volume to water in medication tank, stirring thoroughly.

DILUTION RATES:

Treatment of

E. coli

, Pasteurella Haemophilus and Staphylococcal infections in chickens:-

1mL to 4.5 litres water.

Treatment of Salmonella infection of chickens and diarrhoea in pigs:- 3mL to 4.5 litres

water.

Treatment of bacterial infections in turkeys:- 15mL per 500 kg flock liveweight in water

consumed daily.

Recommended dilution rates apply when water consumption is normal; if sub-normal,

increase concentration to administer 15-30 mg active ingredients per kg total liveweight per

day. Continue treatment for 3-5 days according to severity of disease.

Any variation by the prescribing veterinarian to the approved dose, frequency,

duration, route, disease or target species may result in the need to extend the approved

withholding period.

TRIBRISSEN WATER MEDICATION – IMMEDIATE CONTAINER

200mL LABEL

SIDE PANEL (2)

WITHHOLDING PERIODS:

DO NOT USE less than 14 days before slaughter for human consumption.

DO NOT USE in birds which are producing or may in the future produce eggs or egg

products for human consumption.

Made in Australia by:

JUROX Pty. Ltd.

85 Gardiners Road

Rutherford NSW 2320 Australia

Infoline 1 800 023 312

Under licence from:

Schering-Plough Animal Health

(A Division of Schering-Plough Pty Ltd)

® Schering-Plough Pty Ltd Registered Trademark

DISPOSE of container by wrapping with paper and putting in garbage.

STORE below 25

C (Air Conditioning).

PROTECT FROM LIGHT.

EXP.

NRA 36123/0500

1-1-2019

Aurobindo Pharma USA, Inc. Initiates Voluntary Nationwide Consumer Level Recall of 80 Lots of Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets, USP and Valsartan Tablets USP, Due to the Detection of NDEA (N-Nitrosodiethylamine) Impurity

Aurobindo Pharma USA, Inc. Initiates Voluntary Nationwide Consumer Level Recall of 80 Lots of Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets, USP and Valsartan Tablets USP, Due to the Detection of NDEA (N-Nitrosodiethylamine) Impurity

Aurobindo Pharma USA, Inc. is conducting a voluntary recall of 80 lots of Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets, USP and Valsartan Tablets USP to the consumer level due to the detection of trace amounts of an unexpected impurity found in the finished drug product. The impurity detected in the finished drug product is N-nitrosodiethylamine (NDEA), which is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, and has been classifi...

FDA - U.S. Food and Drug Administration

13-12-2018

Evaluation of the safety and efficacy of the organic acids lactic and acetic acids to reduce microbiological surface contamination on pork carcasses and pork cuts

Evaluation of the safety and efficacy of the organic acids lactic and acetic acids to reduce microbiological surface contamination on pork carcasses and pork cuts

Published on: Wed, 12 Dec 2018 Studies evaluating the safety and efficacy of lactic and acetic acids to reduce microbiological surface contamination on pork carcasses pre‐chill and pork meat cuts post‐chill were assessed. Lactic acid treatments consisted of 2–5% solutions at temperatures of up to 80°C applied to carcasses by spraying or up to 55°C applied on cuts by spraying or dipping. Acetic acid treatments consisted of 2–4% solutions at temperatures of up to 40°C applied on carcasses by spraying or o...

Europe - EFSA - European Food Safety Authority Publications

28-11-2018

Information Update - Mylan-Valsartan medications voluntarily recalled as a precaution due to an impurity

Information Update - Mylan-Valsartan medications voluntarily recalled as a precaution due to an impurity

Mylan Pharmaceuticals ULC is voluntarily recalling four lots of Mylan-Valsartan tablets (40 mg, 80 mg, 160 mg and 320 mg strength) after testing found low levels of an impurity, N-nitrosodiethylamine (NDEA).

Health Canada

21-11-2018

Mylan Initiates Voluntary Nationwide Recall of 15 Lots of Valsartan Tablets, USP, Amlodipine and Valsartan Tablets, USP, and Valsartan and Hydrochlorothiazide Tablets, USP, Due to the Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine) Impurity Fou

Mylan Initiates Voluntary Nationwide Recall of 15 Lots of Valsartan Tablets, USP, Amlodipine and Valsartan Tablets, USP, and Valsartan and Hydrochlorothiazide Tablets, USP, Due to the Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine) Impurity Fou

Mylan N.V. (NASDAQ: MYL) today announced that its U.S. based Mylan Pharmaceuticals business is conducting a voluntary nationwide recall to the consumer level of select lots of Valsartan-containing products, including six lots of Amlodipine and Valsartan Tablets, USP (including the 5mg/160mg, 10mg/160mg, and 10mg/320mg strengths), seven lots of Valsartan Tablets, USP (including 40 mg, 80 mg, 160 mg, and 320 mg strengths), and two lots of Valsartan and Hydrochlorothiazide Tablets, USP 320mg/25mg strength. ...

FDA - U.S. Food and Drug Administration

There are no news related to this product.